Global Drugs for Non-small Cell Lung Cancer Market Analysis 2016-2020 and Forecast 2021-2026

Table of Contents
1 Industry Overview
1.1 Drugs for Non-small Cell Lung Cancer Industry
Figure Drugs for Non-small Cell Lung Cancer Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Drugs for Non-small Cell Lung Cancer
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Drugs for Non-small Cell Lung Cancer
1.2.2 Downstream
Table Application Segment of Drugs for Non-small Cell Lung Cancer
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Drugs for Non-small Cell Lung Cancer Market by Type
3.1 By Type
3.1.1 Radiofrequency Ablation (RFA)
Table Major Company List of Radiofrequency Ablation (RFA)
3.1.2 Radiation Therapy
Table Major Company List of Radiation Therapy
3.1.3 Chemotherapy
Table Major Company List of Chemotherapy
3.1.4 Targeted Therapies
Table Major Company List of Targeted Therapies
3.1.5 Immunotherapy
Table Major Company List of Immunotherapy
3.2 Market Size
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2020, by Type, in USD Million
Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2016-2020, by Type, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2020, by Type, in Volume
Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2026, by Type, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.1.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.1.2 Bristol-Myers Squibb Products & Services
4.1.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.2.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.2.2 GlaxoSmithKline Products & Services
4.2.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Menarini (Company Profile, Sales Data etc.)
4.3.1 Menarini Profile
Table Menarini Overview List
4.3.2 Menarini Products & Services
4.3.3 Menarini Business Operation Conditions
Table Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi (Company Profile, Sales Data etc.)
4.4.1 Sanofi Profile
Table Sanofi Overview List
4.4.2 Sanofi Products & Services
4.4.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Ziopharm Oncology (Company Profile, Sales Data etc.)
4.5.1 Ziopharm Oncology Profile
Table Ziopharm Oncology Overview List
4.5.2 Ziopharm Oncology Products & Services
4.5.3 Ziopharm Oncology Business Operation Conditions
Table Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Alchemia (Company Profile, Sales Data etc.)
4.6.1 Alchemia Profile
Table Alchemia Overview List
4.6.2 Alchemia Products & Services
4.6.3 Alchemia Business Operation Conditions
Table Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Amgen (Company Profile, Sales Data etc.)
4.7.1 Amgen Profile
Table Amgen Overview List
4.7.2 Amgen Products & Services
4.7.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Apotex (Company Profile, Sales Data etc.)
4.8.1 Apotex Profile
Table Apotex Overview List
4.8.2 Apotex Products & Services
4.8.3 Apotex Business Operation Conditions
Table Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 BioMarin Pharmaceutical (Company Profile, Sales Data etc.)
4.9.1 BioMarin Pharmaceutical Profile
Table BioMarin Pharmaceutical Overview List
4.9.2 BioMarin Pharmaceutical Products & Services
4.9.3 BioMarin Pharmaceutical Business Operation Conditions
Table Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 CellAct Pharma (Company Profile, Sales Data etc.)
4.10.1 CellAct Pharma Profile
Table CellAct Pharma Overview List
4.10.2 CellAct Pharma Products & Services
4.10.3 CellAct Pharma Business Operation Conditions
Table Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Cerulean Pharma (Company Profile, Sales Data etc.)
4.11.1 Cerulean Pharma Profile
Table Cerulean Pharma Overview List
4.11.2 Cerulean Pharma Products & Services
4.11.3 Cerulean Pharma Business Operation Conditions
Table Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Cipla (Company Profile, Sales Data etc.)
4.12.1 Cipla Profile
Table Cipla Overview List
4.12.2 Cipla Products & Services
4.12.3 Cipla Business Operation Conditions
Table Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
4.13 Cornerstone Pharmaceuticals (Company Profile, Sales Data etc.)
4.13.1 Cornerstone Pharmaceuticals Profile
Table Cornerstone Pharmaceuticals Overview List
4.13.2 Cornerstone Pharmaceuticals Products & Services
4.13.3 Cornerstone Pharmaceuticals Business Operation Conditions
Table Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Curis (Company Profile, Sales Data etc.)
4.14.1 Curis Profile
Table Curis Overview List
4.14.2 Curis Products & Services
4.14.3 Curis Business Operation Conditions
Table Business Operation of Curis (Sales Revenue, Cost, Gross Margin)
4.15 CytRx (Company Profile, Sales Data etc.)
4.15.1 CytRx Profile
Table CytRx Overview List
4.15.2 CytRx Products & Services
4.15.3 CytRx Business Operation Conditions
Table Business Operation of CytRx (Sales Revenue, Cost, Gross Margin)
4.16 Eli Lilly (Company Profile, Sales Data etc.)
4.16.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.16.2 Eli Lilly Products & Services
4.16.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
4.17 Exelixis (Company Profile, Sales Data etc.)
4.17.1 Exelixis Profile
Table Exelixis Overview List
4.17.2 Exelixis Products & Services
4.17.3 Exelixis Business Operation Conditions
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
4.18 Fresenius Kabi (Company Profile, Sales Data etc.)
4.18.1 Fresenius Kabi Profile
Table Fresenius Kabi Overview List
4.18.2 Fresenius Kabi Products & Services
4.18.3 Fresenius Kabi Business Operation Conditions
Table Business Operation of Fresenius Kabi (Sales Revenue, Cost, Gross Margin)
4.19 Genentech (Company Profile, Sales Data etc.)
4.19.1 Genentech Profile
Table Genentech Overview List
4.19.2 Genentech Products & Services
4.19.3 Genentech Business Operation Conditions
Table Business Operation of Genentech (Sales Revenue, Cost, Gross Margin)
4.20 Hikma Pharmaceuticals (Company Profile, Sales Data etc.)
4.20.1 Hikma Pharmaceuticals Profile
Table Hikma Pharmaceuticals Overview List
4.20.2 Hikma Pharmaceuticals Products & Services
4.20.3 Hikma Pharmaceuticals Business Operation Conditions
Table Business Operation of Hikma Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.21 Hospira (Company Profile, Sales Data etc.)
4.21.1 Hospira Profile
Table Hospira Overview List
4.21.2 Hospira Products & Services
4.21.3 Hospira Business Operation Conditions
Table Business Operation of Hospira (Sales Revenue, Cost, Gross Margin)
4.22 Intas Pharmaceuticals (Company Profile, Sales Data etc.)
4.22.1 Intas Pharmaceuticals Profile
Table Intas Pharmaceuticals Overview List
4.22.2 Intas Pharmaceuticals Products & Services
4.22.3 Intas Pharmaceuticals Business Operation Conditions
Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.23 Karyopharm Therapeutics (Company Profile, Sales Data etc.)
4.23.1 Karyopharm Therapeutics Profile
Table Karyopharm Therapeutics Overview List
4.23.2 Karyopharm Therapeutics Products & Services
4.23.3 Karyopharm Therapeutics Business Operation Conditions
Table Business Operation of Karyopharm Therapeutics (Sales Revenue, Cost, Gross Margin)
4.24 Kyowa Hakko Kirin (Company Profile, Sales Data etc.)
4.24.1 Kyowa Hakko Kirin Profile
Table Kyowa Hakko Kirin Overview List
4.24.2 Kyowa Hakko Kirin Products & Services
4.24.3 Kyowa Hakko Kirin Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin)
4.25 Ligand Pharmaceuticals (Company Profile, Sales Data etc.)
4.25.1 Ligand Pharmaceuticals Profile
Table Ligand Pharmaceuticals Overview List
4.25.2 Ligand Pharmaceuticals Products & Services
4.25.3 Ligand Pharmaceuticals Business Operation Conditions
Table Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2016-2020, by Company, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share in 2020, by Company, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume 2016-2020, by Company, in Volume
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Drugs for Non-small Cell Lung Cancer Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2020
Figure Europe Drugs for Non-small Cell Lung Cancer Market Market Concentration, in 2020
Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer MMarket Concentration, in 2020
Figure South America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2020
Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2016-2020, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2016-2020, in Volume
6.1.2 Demand in Clinic
Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2016-2020, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2016-2020, in Volume
6.1.3 Demand in Others
Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2016-2020, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2021-2026, by Application, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Market Growth 2021-2026, by Application, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Market Share in 2026, by Application, in USD Million
Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2021-2026, by Application, in Volume
Table Drugs for Non-small Cell Lung Cancer Market Growth 2021-2026, by Application, in Volume
Table Drugs for Non-small Cell Lung Cancer Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Drugs for Non-small Cell Lung Cancer Production 2016-2020, by Region, in USD Million
Table Drugs for Non-small Cell Lung Cancer Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2020, by Region, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Market Share 2016-2020, by Region, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2020, by Region, in Volume
Table Global Drugs for Non-small Cell Lung Cancer Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
Table North America Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
Table South America Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2026, by Region, in USD Million
Table Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Table
1. Table Upstream Segment of Drugs for Non-small Cell Lung Cancer
2. Table Application Segment of Drugs for Non-small Cell Lung Cancer
3. Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Radiation Therapy
5. Table Major Company List of Chemotherapy
6. Table Major Company List of Targeted Therapies
7. Table Major Company List of Immunotherapy
8. Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2020, by Type, in USD Million
9. Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2020, by Type, in Volume
10. Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2026, by Type, in USD Million
11. Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2026, by Type, in Volume
12. Table Bristol-Myers Squibb Overview List
13. Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table GlaxoSmithKline Overview List
15. Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Menarini Overview List
17. Table Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Sanofi Overview List
19. Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Ziopharm Oncology Overview List
21. Table Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Alchemia Overview List
23. Table Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Amgen Overview List
25. Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Apotex Overview List
27. Table Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table BioMarin Pharmaceutical Overview List
29. Table Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table CellAct Pharma Overview List
31. Table Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Cerulean Pharma Overview List
33. Table Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
34. Table Cipla Overview List
35. Table Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
36. Table Cornerstone Pharmaceuticals Overview List
37. Table Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
38. Table Curis Overview List
39. Table Business Operation of Curis (Sales Revenue, Cost, Gross Margin)
40. Table CytRx Overview List
41. Table Business Operation of CytRx (Sales Revenue, Cost, Gross Margin)
42. Table Eli Lilly Overview List
43. Table Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
44. Table Exelixis Overview List
45. Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
46. Table Fresenius Kabi Overview List
47. Table Business Operation of Fresenius Kabi (Sales Revenue, Cost, Gross Margin)
48. Table Genentech Overview List
49. Table Business Operation of Genentech (Sales Revenue, Cost, Gross Margin)
50. Table Hikma Pharmaceuticals Overview List
51. Table Business Operation of Hikma Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
52. Table Hospira Overview List
53. Table Business Operation of Hospira (Sales Revenue, Cost, Gross Margin)
54. Table Intas Pharmaceuticals Overview List
55. Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
56. Table Karyopharm Therapeutics Overview List
57. Table Business Operation of Karyopharm Therapeutics (Sales Revenue, Cost, Gross Margin)
58. Table Kyowa Hakko Kirin Overview List
59. Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin)
60. Table Ligand Pharmaceuticals Overview List
61. Table Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
62. Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2016-2020, by Company, in USD Million
63. Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share 2016-2020, by Company, in USD Million
64. Table Global Drugs for Non-small Cell Lung Cancer Sales Volume 2016-2020, by Company, in Volume
65. Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share 2016-2020, by Company, in Volume
66. Table Regional Demand Comparison List
67. Table Major Application in Different Regions
68. Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2021-2026, by Application, in USD Million
69. Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2021-2026, by Application, in Volume
70. Table Drugs for Non-small Cell Lung Cancer Market Growth 2021-2026, by Application, in Volume
71. Table Drugs for Non-small Cell Lung Cancer Market Share in 2026, by Application, in Volume
72. Table Drugs for Non-small Cell Lung Cancer Production 2016-2020, by Region, in USD Million
73. Table Drugs for Non-small Cell Lung Cancer Production 2016-2020, by Region, in Volume
74. Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2020, by Region, in USD Million
75. Table Global Drugs for Non-small Cell Lung Cancer Market Share 2016-2020, by Region, in USD Million
76. Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2020, by Region, in Volume
77. Table Global Drugs for Non-small Cell Lung Cancer Market Share 2016-2020, by Region, in Volume
78. Table North America Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
79. Table North America Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
80. Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
81. Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
82. Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
83. Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
84. Table South America Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
85. Table South America Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
86. Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in USD Million
87. Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2016-2020, by Country, in Volume
88. Table Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2026, by Region, in USD Million
89. Table Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2026, by Region, in Volume
90. Table Price Factors List

List of Figure
1. Figure Drugs for Non-small Cell Lung Cancer Industry Chain Structure
2. Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2016-2020, by Type, in Volume
4. Figure Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Drugs for Non-small Cell Lung Cancer Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2020
7. Figure Europe Drugs for Non-small Cell Lung Cancer Market Market Concentration, in 2020
8. Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer MMarket Concentration, in 2020
9. Figure South America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2020
10. Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Concentration, in 2020
11. Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2016-2020, in USD Million
12. Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2016-2020, in Volume
13. Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2016-2020, in USD Million
14. Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2016-2020, in Volume
15. Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2016-2020, in USD Million
16. Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2016-2020, in Volume
17. Figure Drugs for Non-small Cell Lung Cancer Market Growth 2021-2026, by Application, in USD Million
18. Figure Drugs for Non-small Cell Lung Cancer Market Share in 2026, by Application, in USD Million
19. Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
20. Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
21. Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
25. Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
26. Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview